|
|
| | Ethyl 4-hydroxypyrimidine-5-carboxylate Basic information |
| Product Name: | Ethyl 4-hydroxypyrimidine-5-carboxylate | | Synonyms: | 6-Hydroxypyrimidine-5-carboxylic acid ethyl ester;4-hydroxy-5-pyrimidinecarboxylicaciethylester;ETHYL 4-HYDROXYPYRIMIDINE-5-CARBOXYLATE;6-OXO-1,6-DIHYDRO-PYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER;4-HYDROXY-PYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER;5-Pyrimidinecarboxylic acid, 1,4-dihydro-4-oxo-, ethyl ester;Ethyl 6-oxo-1,6-dihydropyrimidine-5-carboxylate LR;Ethyl 1,4-dihydro-4-oxo-5-pyrimidinecarboxylate | | CAS: | 4786-52-1 | | MF: | C7H8N2O3 | | MW: | 168.15 | | EINECS: | | | Product Categories: | pharmacetical;Heterocycle-Pyrimidine series;CMLLYL | | Mol File: | 4786-52-1.mol |  |
| | Ethyl 4-hydroxypyrimidine-5-carboxylate Chemical Properties |
| Melting point | 185-186 °C | | density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | Inert atmosphere,Room Temperature | | pka | 7.70±0.40(Predicted) |
| HazardClass | IRRITANT | | HS Code | 2933599590 |
| | Ethyl 4-hydroxypyrimidine-5-carboxylate Usage And Synthesis |
| Uses | 7-Chloroisoquinolin-1(2H)-one acts as a reagent for the preparation, SAR of methoxyisoquinoline derivative and discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection. Synthesis and pharmacological evaluation of a series of 1,2-dihydro-1-[(5-methyl-1-imidazol-4-yl)methyl]-2-oxopyridine 5-HT3 antagonists. |
| | Ethyl 4-hydroxypyrimidine-5-carboxylate Preparation Products And Raw materials |
|